Đang chuẩn bị liên kết để tải về tài liệu:
Prostate cancer - Diagnosis and treatment

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

For men with metastatic prostate cancer who are willing to accept the adverse impact on over- all survival and gynaecomastia in the hope of retaining sexual function, anti-androgen mono- therapy with bicalutamide (150 mg) 14 is appropriate. Healthcare professionals should begin androgen withdrawal and stop bicalutamide treatment in men with metastatic prostate cancer who are taking bicalutamide monotherapy and who do not maintain satisfactory sexual function. Intermittent androgen withdrawal may be offered to men with metastatic prostate cancer pro- viding they are informed that there is no long-term evidence of its effectiveness. .

TÀI LIỆU LIÊN QUAN

Doctor of Medicine summary: Studying the application of 12-core prostate biopsy by transrectal ultrasound guidance for diagnosis of prostate cancer

A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells

Diagnosis and clinical management in prostate cancer: Part 2

Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: A nationwide, populationbased cohort study

Time from diagnosis to surgery and prostate cancer survival: A retrospective cohort study

Men’s perceptions of prostate cancer diagnosis and care: Insights from qualitative interviews in Victoria, Australia

Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: An observational casecontrol study

Diagnosis and clinical management in prostate cancer: Part 1

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: A prospective study in the Swedish AMORIS cohort

Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: Results from a multicenter biopsy study
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.